Effect of intensity modulated radiotherapy on lymphocytes in patients with esophageal squamous cell carcinoma and its clinical significance

Effect of intensity modulated radiotherapy on lymphocytes in patients with esophageal squamous cell carcinoma and its clinical significance

BackgroundRadiotherapy usually leads to a decrease in the total number of lymphocytes in patients with esophageal cancer. The factors that causing lymphopenia and the clinical significance of lymphopenia are studied in this article.Patients and methods110 patients with esophageal squamous cell carci...

Full description

Bibliographic Details
Main Authors:	Xiufang Tian, Yong Hou, Jianping Guo, Haiyan Wu, Limin Nie, Hang Wang, Yan Zhang, Yajuan Lv
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Oncology
Subjects:	esophageal squamous cell carcinoma lymphopenia nutritional factors survival radiotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1096386/full

Similar Items

Immunotherapy with or without radiotherapy for metastatic or recurrent esophageal squamous cell carcinoma: A real-world study
by: Xiaoyue Wu, et al.
Published: (2023-01-01)

Involved-field irradiation or elective-nodal irradiation in neoadjuvant chemo-radiotherapy for locally-advanced esophageal cancer: comprehensive analysis for dosimetry, treatment-related complications, impact on lymphocyte, patterns of failure and survival
by: Xianyan Chen, et al.
Published: (2023-10-01)

The Impact of Radiotherapy Dose in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy
by: Chien-Ming Lo, et al.
Published: (2021-03-01)

Novel Photodynamic Therapy for Esophageal Squamous Cell Carcinoma following Radiotherapy
by: Takumi Yanagita, et al.
Published: (2023-05-01)

A review on lymphocyte radiosensitivity and its impact on radiotherapy
by: Harald Paganetti, et al.
Published: (2023-08-01)

Dosimetric analysis and biological evaluation between proton radiotherapy and photon radiotherapy for the long target of total esophageal squamous cell carcinoma
by: Yongbin Cui, et al.
Published: (2022-10-01)

Predicting the efficacy of radiotherapy for esophageal squamous cell carcinoma based on enhanced computed tomography radiomics and combined models
by: Jihui Liu, et al.
Published: (2023-03-01)

Effectiveness of image‐guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy
by: Yao‐Hung Kuo, et al.
Published: (2020-01-01)

Malignant Broncho-Oesophageal Fistula following Radiotherapy for Noninvasive T3 Oesophageal Squamous Cell Carcinoma
by: Dwayne Reading, et al.
Published: (2022-05-01)

PD0166285 sensitizes esophageal squamous cell carcinoma to radiotherapy by dual inhibition of WEE1 and PKMYT1
by: Qingyi Zhang, et al.
Published: (2022-11-01)

Cardiac substructures dosimetric predicts cardiac toxicity and prognosis in esophageal squamous cell cancer treated by radiotherapy
by: Zhicheng Jin, et al.
Published: (2024-02-01)

Higher radiation dose on immune cells is associated with radiation-induced lymphopenia and worse prognosis in patients with locally advanced esophageal squamous cell carcinoma
by: Jianjian Qiu, et al.
Published: (2023-05-01)

High vs. low radiotherapy dose in locally advanced esophageal squamous cell carcinoma patients treated with neoadjuvant concurrent chemoradiotherapy: an endemic area population-based study
by: Chia-Chin Li, et al.
Published: (2022-11-01)

Low versus high dose of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma: a propensity score‐matched analysis
by: Qiwei Yao, et al.
Published: (2023-06-01)

Factors affecting survival in esophageal squamous cell carcinoma: Single-center experience
by: Abdullah Sakin, et al.
Published: (2020-05-01)

High-dose Intensity-modulated proton therapy versus Standard-dose Intensity-modulated RadIation therapy for esophageal squamous cell carcinoma (HI-SIRI): study protocol for a randomized controlled clinical trial
by: Chawalit Lertbutsayanukul, et al.
Published: (2022-10-01)

Prognostic value of circulating tumour DNA during post‐radiotherapy surveillance in locally advanced esophageal squamous cell carcinoma
by: Xin Wang, et al.
Published: (2022-11-01)

Editorial: Radiotherapy for esophageal cancer: Molecular mechanism and novel targets to improve radiosensitivity
by: Yanqing Liu, et al.
Published: (2023-04-01)

Effect of Radiation Therapy on Composition of Lymphocyte Populations in Patients with Primary Breast Cancer
by: Irina Kobzeva, et al.
Published: (2023-09-01)

Radiation-induced lymphopenia and the survival of women with cervical cancer: a meta-analysis
by: Hongming Cao, et al.
Published: (2023-12-01)

Survival and prognostic factors in patients with synchronous multiple primary esophageal squamous cell carcinoma receiving definitive radiotherapy: A propensity score-matched analysis
by: Wenyi Wang, et al.
Published: (2023-03-01)

Treatment mode and prognosis of esophageal perforation after radiotherapy in patients with esophageal carcinoma
by: Zhen Chan-Jun, et al.
Published: (2023-01-01)

Expression of FGL1, Distribution of Tumor-Infiltrating Lymphocytes, and Their Clinical Significance in Esophageal Squamous-Cell Carcinoma
by: LIU Yao, et al.
Published: (2022-10-01)

Current and future on definitive concurrent chemoradiotherapy for inoperable locally advanced esophageal squamous cell carcinoma
by: Renxian Xie, et al.
Published: (2024-01-01)

Genetic variant of ADH1C for predicting survival in esophageal squamous cell cancer patients who underwent postoperative radiotherapy
by: Xin Xu, et al.
Published: (2022-09-01)

Expression and clinical significance of phosphorylated FGFR1Y654 in esophageal squamous cell carcinoma
by: DU Dan, et al.
Published: (2024-02-01)

Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma
by: Linxiu Liu, et al.
Published: (2023-04-01)

Comparative transcriptome characterization of esophageal squamous cell carcinoma and adenocarcinoma
by: Xianfeng Li, et al.
Published: (2023-01-01)

Prognostic significance of baseline peripheral blood lymphocyte subsets on second-line immunotherapy in advanced esophageal squamous cell carcinoma
by: Qike Wang, et al.
Published: (2023-08-01)

Outcomes and prognostic factors for patients with cervical esophageal cancer undergoing definitive radiotherapy or chemoradiotherapy
by: Xin-xin Du, et al.
Published: (2019-05-01)

Clinical and prognostic significance of perioperative change in red cell distribution width in patients with esophageal squamous cell carcinoma
by: Peng Zhang, et al.
Published: (2023-04-01)

The prognostic value of tumor length to resectable esophageal squamous cell carcinoma: a retrospective study
by: Xiangwei Zhang, et al.
Published: (2017-01-01)

Neoadjuvant Carboplatin/Paclitaxel versus 5-Fluorouracil/Cisplatin in Combination with Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Comparative Study
by: Xing Gao, et al.
Published: (2022-05-01)

Efficacy of adjuvant chemotherapy on overall survival in patients with lymph node‐positive esophageal squamous cell carcinoma: Is oral chemotherapy promising?
by: Shuogui Fang, et al.
Published: (2023-02-01)

Association between dietary retinol and prognosis of patients with esophageal squamous cell carcinoma
by: ZENG Qiaoyan, et al.
Published: (2022-11-01)

Corrigendum: Brain Metastases from Esophageal Squamous Cell Carcinoma: Clinical Characteristics and Prognosis
by: Linlin Xiao, et al.
Published: (2022-02-01)

Overview of Risk Factors for Esophageal Squamous Cell Carcinoma in China
by: Erica Conway, et al.
Published: (2023-11-01)

Esophageal squamous cell carcinoma presenting as a submucosal tumor
by: Lin Yang, et al.
Published: (2023-08-01)

PARPi increases radiotherapy sensitivity of esophageal squamous cell carcinoma by inhibiting XRCC1 expression
by: LI Yiping, et al.
Published: (2023-06-01)

Phase I study of cisplatin and nanoparticle albumin‐bound‐paclitaxel combined with concurrent radiotherapy in locally advanced esophageal squamous cell carcinoma
by: Hui Jiang, et al.
Published: (2023-07-01)